References
- Lozupone M, La Montagna M, Sardone R, et al. Can pharmacotherapy effectively reduce Alzheimer’s related agitation? Expert Opin Pharmacother. 2020 Jun 1;1–6. DOI:10.1080/14656566.2020.1770730. *The subject of this letter to the Editor.
- Nagata T, Shinagawa S, Nakajima S, et al. Pharmacological management of behavioral disturbances in patients with Alzheimer’s disease. Expert Opin Pharmacother. 2020;21(9):1093–1102.*The subject of this letter to the Editor.
- Alzheimer A. Über eine eigenartige Erkrankung der Hirnrinde. Allgemeine Zeitschrift fur Psychiatrie und Psychisch-gerichtliche Medizin. 1907 Jan;64:146–148.
- Tariot PN, Blazina L. The psychopathology of dementia. In: Morris J, editor. Handbook of dementing illnesses. New York, NY: Marcel Dekker; 1993. p. 461–475.
- Wilson RS, Mendes de Leon CF, Barnes LL, et al. Participation in cognitively stimulating activities and risk of incident Alzheimer disease. JAMA. 2002;287(6):742–748.
- Cummings JL. Cognitive and behavioral heterogeneity in Alzheimer’s disease: seeking the neurobiological basis. Neurobiol Aging. 2000;21:845–861.
- Kosel F, Pelley JMS, Franklin TB. Behavioural and psychological symptoms of dementia in mouse models of Alzheimer’s disease-related pathology. Neurosci Biobehav Rev. 2020;112:634–647.
- Zhang Q, Yang C, Liu T, et al. Citalopram restores short-term memory deficit and non-cognitive behaviors in APP/PS1 mice while halting the advance of Alzheimer’s disease-like pathology. Neuropharmacology. 2018;131:475–486.
- Porsteinsson AP, Drye LT, Pollack BG, et al. Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial. JAMA. 2014;311(7):682–691.
- Bangen KJ, Nation DA, Delano-Wood L, et al. Aggregate effects of vascular risk factors on cerebrovascular changes in autopsy-confirmed Alzheimer’s disease. Alzheimers Dement. 2015 Apr;11(4):394–403.
- Toyama K, Spin JM, Mogi M, et al. Therapeutic perspective on vascular cognitive impairment. Pharmacol Res. 2019Aug;146:104266.
- Victoroff J, Lin FV, Coburn KL, et al. Noncognitive behavioral changes associated with Alzheimer’s disease: implications of neuroimaging findings. J Neuropsychiatry Clin Neurosci. 2018;30(1):14–21.